Neuroendocrine Tumors (NETs): Breakthroughs in Diagnosis & Treatment
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Neuroendocrine Tumors (NETs): Breakthroughs in Diagnosis & Treatment
-
Narrated by:
-
By:
About this listen
Welcome to vpod.ai’s The Deep Dive, proudly sponsored by StoneFly. In this episode, we explore the complex, often misunderstood world of neuroendocrine tumors (NETs)—from silent symptoms to cutting-edge treatments revolutionizing outcomes.
You'll learn:
- What NETs are, where they originate, and why the term “carcinoid” is outdated
- How carcinoid syndrome causes symptoms like flushing, diarrhea, and heart issues
- The step-by-step diagnostic process, from biomarkers to biopsy
- Why surgery remains vital—and what’s next when surgery isn’t enough
- Advances in somatostatin analogs, Everolimus, and targeted therapies
- Game-changers like CAR-T cell therapy, new immunotherapy combinations, and anti-angiogenesis drugs
- How the latest FDA approvals are reshaping care for advanced and aggressive NETs
This is the frontline of rare cancer research—where collaboration, innovation, and precision medicine are making a real difference.
What listeners say about Neuroendocrine Tumors (NETs): Breakthroughs in Diagnosis & Treatment
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.